First Time Loading...

Codexis Inc
NASDAQ:CDXS

Watchlist Manager
Codexis Inc Logo
Codexis Inc
NASDAQ:CDXS
Watchlist
Price: 2.66 USD 0.38% Market Closed
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

CDXS Price Targets Summary
Codexis Inc

Wall Street analysts forecast CDXS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CDXS is 6.7 USD with a low forecast of 3.03 USD and a high forecast of 10.5 USD.

CDXS Lowest Forecast
Wall Street Target
3.03 USD
14% Upside
CDXS Average Forecast
Wall Street Target
6.7 USD
152% Upside
CDXS Highest Forecast
Wall Street Target
10.5 USD
295% Upside
Lowest
Price Target
3.03 USD
14% Upside
Average
Price Target
6.7 USD
152% Upside
Highest
Price Target
10.5 USD
295% Upside
Codexis Inc Competitors:
Price Targets
VIMTALABS
Vimta Labs Ltd
36% Upside
M
038290
Macrogen Inc
95% Upside
688621
Beijing Sun-Novo Pharmaceutical Research Co Ltd
32% Upside
CDXC
Chromadex Corp
92% Upside
VIMTALABS
Vimta Labs Ltd
36% Upside
M
038290
Macrogen Inc
95% Upside
688621
Beijing Sun-Novo Pharmaceutical Research Co Ltd
32% Upside
CDXC
Chromadex Corp
92% Upside
RGEN
Repligen Corp
25% Upside
M
300463
Maccura Biotechnology Co Ltd
48% Upside
F
FTRE
Fortrea Holdings Inc
14% Upside
O
ORPH
Open Orphan PLC
199% Upside

Revenue
Forecast

Revenue Estimate
Codexis Inc

For the last 8 years the compound annual growth rate for Codexis Inc's revenue is 7%. The projected CAGR for the next 3 years is 7%.

7%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Codexis Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Codexis Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-28%
Average Miss
What are analyst estimates?

See Also

Summary
CDXS intrinsic value, competitors valuation, and company profile.
DCF Valuation
CDXS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CDXS stock valuation using valuation multiples.
Wall Street Estimates
CDXS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CDXS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CDXS's stock price target?
Price Target
6.7 USD

According to Wall Street analysts, the average 1-year price target for CDXS is 6.7 USD with a low forecast of 3.03 USD and a high forecast of 10.5 USD.

What is Codexis Inc's Revenue forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Codexis Inc's revenue is 7%. The projected CAGR for the next 3 years is 7%.

ALPHA SPREAD
Join more than 132,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.